PuraPharm Corporation Limited (HKG:1498)
0.2800
0.00 (0.00%)
Aug 27, 2026, 4:08 PM HKT
PuraPharm Corporation Market Cap
PuraPharm Corporation has a market cap or net worth of 149.81 million as of August 27, 2026. Its market cap has decreased by -17.56% in one year.
Market Cap
149.81M
Enterprise Value
508.20M
Revenue
323.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.28
ChartMarket Cap Chart
Since July 8, 2015, PuraPharm Corporation's market cap has decreased from 861.75M to 149.81M, a decrease of -82.62%. That is a compound annual growth rate of -14.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 149.81M | -21.13% |
| Dec 31, 2025 | 189.94M | -12.58% |
| Dec 31, 2024 | 217.28M | -38.89% |
| Dec 29, 2023 | 355.55M | -29.69% |
| Dec 30, 2022 | 505.67M | 58.47% |
| Dec 31, 2021 | 319.09M | 19.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lee's Pharmaceutical Holdings | 668.33M |
| Zhongzhi Pharmaceutical Holdings | 591.57M |
| China NT Pharma Group Company | 398.58M |
| Wai Yuen Tong Medicine Holdings | 323.17M |
| Regent Pacific Group | 259.72M |
| Tianda Pharmaceuticals | 240.80M |
| Extrawell Pharmaceutical Holdings | 226.20M |
| Shenzhen Neptunus Interlong Bio-technique Company | 182.90M |